Ataxion Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Ataxion General Information
Description
Developer of novel small-molecule therapeutics designed for neurological diseases. The company's novel small-molecule therapeutics offers a treatment of hereditary ataxia based on ion-channel modulators, enabling patients to treat ataxia associated with other degenerative neurological disorders including multiple sclerosis and huntington's disease.
Contact Information
Website
www.ataxiontherapeutics.comCorporate Office
- 400 Technology Square
- 10th Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 400 Technology Square
- 10th Floor
- Cambridge, MA 02139
- United States
Ataxion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 06-Mar-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 17-Mar-2014 | Completed | Startup | |||
| 1. Seed Round | 01-Apr-2013 | Completed | Startup |
Ataxion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A1 |
Ataxion Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| Biogen | Corporation | Minority | ||
| Saniona | Corporation | Minority |
Ataxion FAQs
-
When was Ataxion founded?
Ataxion was founded in 2013.
-
Where is Ataxion headquartered?
Ataxion is headquartered in Cambridge, MA.
-
What industry is Ataxion in?
Ataxion’s primary industry is Drug Discovery.
-
Is Ataxion a private or public company?
Ataxion is a Private company.
-
What is Ataxion’s current revenue?
The current revenue for Ataxion is .
-
How much funding has Ataxion raised over time?
Ataxion has raised $17M.
-
Who are Ataxion’s investors?
Atlas Venture, Biogen, and Saniona have invested in Ataxion.
-
When was Ataxion acquired?
Ataxion was acquired on 06-Mar-2017.
-
Who acquired Ataxion?
Ataxion was acquired by Cadent Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process